04-23854. New Animal Drugs; Correction of Sponsor's Drug Labeler Codes  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule; technical amendment.

    SUMMARY:

    The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a correction of sponsor's drug labeler code for Pennfield Oil Co.

    DATES:

    This rule is effective October 26, 2004.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: david.newkirk@fda.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    FDA has found that the animal drug regulations do not reflect the correct sponsor's drug labeler code for Pennfield Oil Co. Accordingly, the agency is amending the regulations in 21 CFR 510.600, 520.445b, 520.1660d, 522.1660a, 558.76, 558.78, 558.128, 558.140, 558.145, 558.195, 558.355, 558.450, 558.550, 558.600, 558.625, and 558.630 to correct this error.

    This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

    Start List of Subjects

    List of Subjects

    21 CFR Part 510

    • Administrative practice and procedure
    • Animal drugs
    • Labeling
    • Reporting and recordkeeping requirements

    21 CFR Parts 520 and 522

    • Animal drugs

    21 CFR Part 558

    • Animal drugs
    • Animal feeds
    End List of Subjects Start Amendment Part

    Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, and 558 are amended as follows:

    End Amendment Part Start Part

    PART 510—NEW ANIMAL DRUGS

    End Part Start Amendment Part

    1. The authority citation for 21 CFR part 510 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

    End Authority Start Amendment Part

    2. Section 510.600 is amended in the table in paragraph (c)(1) in the entry for “Pennfield Oil Co.” by removing “053389” and by adding in its place “048164”; and in the table in paragraph (c)(2) by removing the entry for “053389” and by adding in numerical sequence an entry for “048164” to read as follows:

    End Amendment Part
    Names, addresses, and drug labeler codes of sponsors of approved applications.

    (c) * * *

    (1) * * *

    Firm name and addressDrug labeler code
    *    *    *    *    *
    Pennfield Oil Co., 14040 Industrial Rd., Omaha, NE 68144048164
    *    *    *    *    *

    (2) * * *

    Drug labeler codeFirm name and address
    *    *    *    *    *
    048164Pennfield Oil Co., 14040 Industrial Rd., Omaha, NE 68144
    *    *    *    *    *
    Start Part

    PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    3. The authority citation for 21 CFR part 520 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    4. Section 520.445b is amended in paragraph (b) by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    5. Section 520.1660d is amended in paragraph (b)(6) by removing “053389” and by adding in its place “048164”.

    End Amendment Part Start Part

    PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

    End Part Start Amendment Part

    6. The authority citation for 21 CFR part 522 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b.

    End Authority
    [Amended]
    Start Amendment Part

    7. Section 522.1660a is amended in paragraph (b) by removing “053389” and by adding in its place “048164”.

    End Amendment Part Start Part

    PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

    End Part Start Amendment Part

    8. The authority citation for 21 CFR part 558 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 360b, 371.

    End Authority
    [Amended]
    Start Amendment Part

    9. Section 558.76 is amended in the table in paragraph (d)(1)(iv) in the “Limitations” and “Sponsor” columns by removing “053389” and by adding in its place “048164”.

    End Amendment Part Start Amendment Part

    10. Section 558.78 is amended by revising paragraphs (a) and (b); in the table in paragraph (d)(1) by redesignating paragraphs (d)(1)(ii) through (d)(1)(vi) as paragraphs (d)(1)(iii) through (d)(1)(vii); and by revising paragraph (d)(1)(i); and by adding new paragraph (d)(1)(ii) to read as follows:

    End Amendment Part
    Bacitracin zinc.

    (a) Specifications. Type A medicated articles containing bacitracin zinc equivalent to 5, 10, 25, 40, or 50 grams per pound bacitracin.

    (b) Approvals. See sponsors in § 510.600(c) of this chapter for uses as follows:

    (1) No. 046573: 10, 25, 40, and 50 grams per pound for uses as in paragraph (d) of this section.

    (2) No. 048164: 5 and 50 grams per pound for use as in as in paragraph (d)(1)(i) of this section.

    (d) * * *

    (1) * * *

    Start Printed Page 62407
    Bacitracin zinc in grams per tonCombinations in grams per tonIndications for useLimitationsSponsor
    (i) 4 to 50Chickens: for increased rate of weight gain and improved feed efficiencyGrowing chickens046573 048164
    (ii) 4 to 50Turkeys and pheasants: for increased rate of weight gain and improved feed efficiencyGrowing turkeys and pheasants046573
    *         *         *         *         *         *         *
    [Amended]
    Start Amendment Part

    11. Section 558.128 is amended in paragraph (b)(1) by removing “053389” and by adding in its place “048164”; and in the tables in paragraphs (e)(1), (e)(2), (e)(3), (e)(4), and (e)(5) in the “Sponsor” column by removing “053389” wherever it appears and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    12. Section 558.140 is amended in paragraph (a) by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    13. Section 558.145 is amended in paragraph (a)(2) by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    14. Section 558.195 is amended in the table in paragraph (e)(2)(iii) in the “Limitations” and “Sponsor” columns by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    15. Section 558.355 is amended in paragraph (f)(1)(xiv)(b) by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    16. Section 558.450 is amended in paragraph (a)(2) by removing “053389” and by adding in its place “048164”; in the table in paragraphs (d)(1)(i), (d)(1)(v), (d)(1)(vii), and (d)(1)(viii) in the “Sponsor” column by removing “053389” wherever it appears and by adding in its place “048164”; and in the table in paragraph (d)(1)(ix) in the “Limitations” column by removing “053389” wherever it appears and by adding in its place “048164”.

    End Amendment Part Start Amendment Part

    17. Section 558.550 is amended in paragraphs (d)(1)(xv)( c) and (d)(1)(xvi)(c) by removing “053389” and by adding in its place “048164”; and by revising paragraph (a) and adding paragraph (b) to read as follows:

    End Amendment Part
    Salinomycin.

    (a) Specifications. Type A medicated articles containing 30 or 60 grams of salinomycin activity per pound (as salinomycin sodium biomass).

    (b) Approvals. See sponsors in § 510.600(c) of this chapter for use as in paragraph (d) of this section:

    (1) No. 046573 for use as in paragraph (d) of this section.

    (2) No. 057926 for use as in paragraphs (d)(1)(i), (d)(1)(iii) through (d)(1)(xvi), (d)(2)(i), and (d)(3)(i) of this section.

    (3) No. 048164 for use as in paragraphs (d)(1)(xv) and (d)(1)(xvi) of this section.

    [Amended]
    Start Amendment Part

    18. Section 558.600 is amended in the table in paragraph (e)(1)(iii) in the “Limitations” and “Sponsor” columns by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    19. Section 558.625 is amended in paragraph (b)(89) by removing “053389” and by adding in its place “048164”.

    End Amendment Part
    [Amended]
    Start Amendment Part

    20. Section 558.630 is amended in paragraph (b)(10) by removing “053389” and by adding in numerical sequence “048164”.

    End Amendment Part Start Signature

    Dated: October 14, 2004.

    Steven D. Vaughn,

    Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 04-23854 Filed 10-25-04; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
10/26/2004
Published:
10/26/2004
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; technical amendment.
Document Number:
04-23854
Dates:
This rule is effective October 26, 2004.
Pages:
62406-62407 (2 pages)
PDF File:
04-23854.pdf
CFR: (16)
21 CFR 510.600
21 CFR 558.76
21 CFR 558.78
21 CFR 558.128
21 CFR 558.140
More ...